NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10408	Companies
217627	Keywords
147172	Articles
115155	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 05/04/2026 at 23:34, 10 days 1 hour ago

Nanobiotix modifie le protocole de son étude de phase 3 sur le cancer

FDA NANOBIOTIX Protocole Modifié NANORAY-312 Cancer Tête Et Cou
BRIEF

published on 05/04/2026 at 23:34, 10 days 1 hour ago

Nanobiotix Updates Protocol for Phase 3 Cancer Study

FDA Approval Protocol Amendment Phase 3 Study NANOBIOTIX JNJ-1900
BRIEF

published on 05/04/2026 at 23:34, 10 days 1 hour ago

Nanobiotix modifies the protocol of its phase 3 cancer study

FDA Head And Neck Cancer NANOBIOTIX NANORAY-312 Modified Protocol
BRIEF

published on 05/04/2026 at 23:34, 10 days 1 hour ago

Nanobiotix met à jour le protocole de son étude de phase 3 sur le cancer

Approbation De La FDA Étude De Phase 3 NANOBIOTIX JNJ-1900 Amendement Au Protocole
PRESS RELEASE

published on 05/04/2026 at 23:29, 10 days 1 hour ago

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU
Nanobiotix annonce un amendement du protocole de l'\xe9tude mondiale de phase 3 sur le cancer de la t^ete et du cou, acclrant la voie d'enregistrement de JNJ-1900 (NBTXR3)

Oncologie Protocole Amendement NANOBIOTIX JNJ-1900
PRESS RELEASE

published on 05/04/2026 at 23:29, 10 days 1 hour ago

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
Nanobiotix announces FDA acceptance of protocol amendment to NANORAY-312 study for head and neck cancer, potentially accelerating global registration pathway for JNJ-1900 (NBTXR3)

Head And Neck Cancer Protocol Amendment NANOBIOTIX NBTXR3 JNJ-1900
BRIEF

published on 04/20/2026 at 08:35, 24 days 16 hours ago

Nanobiotix Reveals Enhanced Bioavailability and Reduced Toxicity in Preclinical Study

Preclinical Study Bioavailability NANOBIOTIX Nanoprimer Technology LNP Immunotherapy
BRIEF

published on 04/20/2026 at 08:35, 24 days 16 hours ago

Nanobiotix révèle une biodisponibilité accrue et une toxicité réduite dans une étude préclinique

NANOBIOTIX Étude Préclinique Biodisponibilité Technologie Nanoprimer Immunothérapie Par LNP
PRESS RELEASE

published on 04/20/2026 at 08:30, 24 days 16 hours ago

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
Nanobiotix presents new preclinical data at AACR 2026 showcasing Nanoprimer technology enhancing systemic bioavailability and reducing toxicity for LNP-delivered DNA immunotherapy

Preclinical Data NANOBIOTIX Nanoprimer Technology Systemic Bioavailability Toxicity Reduction
PRESS RELEASE

published on 04/20/2026 at 08:30, 24 days 16 hours ago

Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN delivrées par LNP après traitement avec sa technologie de nan
Nanobiotix annonce de nouvelles données précliniques démontrant une amélioration de la biodisponibilité systémique et la réduction de la toxicité pour des immunothérapies à ADN délivrées par LNP après traitement avec sa technologie de Nanoprimer

NANOBIOTIX Immunothérapies Biodisponibilité Données Précliniques Toxicité

Accesswire

Published on 05/15/2026 at 00:45, 21 minutes ago

Golden Minerals Announces Sale of Minera William, S.A. de C.V. and Equity Financing
Published on 05/15/2026 at 00:20, 46 minutes ago

Gold Basin Resources Announces Filing and Mailing of Meeting Materials for Special Meeting to Approve Arrangement with CANEX
Published on 05/15/2026 at 00:00, 1 hour 6 minutes ago

Redwood AI Announces Optimization Module Update to Reactosphere, Expanding Experimental Planning and Chemical Process Optimization Capabilities
Published on 05/14/2026 at 23:00, 2 hours 6 minutes ago

Route1 Reports Q1 2026 Results and Continued Expansion of Recurring Operational Engagement
Published on 05/14/2026 at 23:00, 2 hours 6 minutes ago

CCL Industries Announces Intention to Renew Normal Course Issuer Bid and Automatic Securities Purchase Plan

View all ACCESSWIRE

EQS Group

Published on 05/15/2026 at 00:05, 1 hour 1 minute ago

ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds
Published on 05/14/2026 at 23:05, 2 hours 1 minute ago

DeFi Technologies Inc. Announces First Quarter 2026 Financial Results with Revenue of $11.2 Million, Net Income of $4.9 Million, and Strong Balance Sheet
Published on 05/14/2026 at 19:55, 5 hours 11 minutes ago

Gastech 2026 to convene global energy leaders in Bangkok as Asia accelerates demand, LNG investment and system transformation
Published on 05/14/2026 at 19:30, 5 hours 36 minutes ago

FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction
Published on 05/14/2026 at 19:18, 5 hours 48 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/14/2026 at 09:03, 16 hours 3 minutes ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 7 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day 7 hours ago

DDV monthly statement at April 30 2026
Published on 05/13/2026 at 18:00, 1 day 7 hours ago

DDV declaration au 30 avril 2026
Published on 05/13/2026 at 18:00, 1 day 7 hours ago

ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires

View all LES ECHOS COMFI WIRE